<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27147489</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-5053</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Gastroenterology &amp; hepatology</Title>
          <ISOAbbreviation>Nat Rev Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Hippo pathway in intestinal regeneration and disease.</ArticleTitle>
        <Pagination>
          <StartPage>324</StartPage>
          <EndPage>337</EndPage>
          <MedlinePgn>324-37</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrgastro.2016.59</ELocationID>
        <Abstract>
          <AbstractText>The Hippo pathway is a signalling cascade conserved from Drosophila melanogaster to mammals. The mammalian core kinase components comprise MST1 and MST2, SAV1, LATS1 and LATS2 and MOB1A and MOB1B. The transcriptional co-activators YAP1 and TAZ are the downstream effectors of the Hippo pathway and regulate target gene expression. Hippo signalling has crucial roles in the control of organ size, tissue homeostasis and regeneration, and dysregulation of the Hippo pathway can lead to uncontrolled cell growth and malignant transformation. Mammalian intestine consists of a stem cell compartment as well as differentiated cells, and its ability to regenerate rapidly after injury makes it an excellent model system to study tissue homeostasis, regeneration and tumorigenesis. Several studies have established the important role of the Hippo pathway in these processes. In addition, crosstalk between Hippo and other signalling pathways provides tight, yet versatile, regulation of tissue homeostasis. In this Review, we summarize studies on the role of the Hippo pathway in the intestine on these physiological processes and the underlying mechanisms responsible, and discuss future research directions and potential therapeutic strategies targeting Hippo signalling in intestinal disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Audrey W</ForeName>
            <Initials>AW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Zhipeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Kun-Liang</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 CA023100</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA132809</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R35 CA196878</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 GM007752</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>101500079</NlmUniqueID>
        <ISSNLinking>1759-5045</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000091102">YAP-Signaling Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C088374">YAP1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.-</RegistryNumber>
          <NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.-</RegistryNumber>
          <NameOfSubstance UI="C108675">TAFAZZIN protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000217" MajorTopicYN="N">Acyltransferases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007420" MajorTopicYN="N">Intestine, Large</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012038" MajorTopicYN="N">Regeneration</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091102" MajorTopicYN="N">YAP-Signaling Proteins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests statement</b>. The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27147489</ArticleId>
        <ArticleId IdType="mid">NIHMS874810</ArticleId>
        <ArticleId IdType="pmc">PMC5642988</ArticleId>
        <ArticleId IdType="doi">10.1038/nrgastro.2016.59</ArticleId>
        <ArticleId IdType="pii">nrgastro.2016.59</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barry ER, Camargo FD. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol. 2013;25:247–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23312716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94:1287–1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25287865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246–257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23467301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4562315</ArticleId>
            <ArticleId IdType="pubmed">25592648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Meng Z, Plouffe SW, Guan KL. Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol. 2015;77:201–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossuyt W, et al.  An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene. 2014;33:1218–1228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4613760</ArticleId>
            <ArticleId IdType="pubmed">23563179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4701972</ArticleId>
            <ArticleId IdType="pubmed">26728553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9:534–546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7698644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7743921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003;114:445–456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003;5:914–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol. 2003;5:921–927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia J, Zhang W, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 2003;17:2514–2519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC218145</ArticleId>
            <ArticleId IdType="pubmed">14561774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003;114:457–467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kango-Singh M, et al.  Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development. 2002;129:5719–5730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12421711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapon N, et al.  salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002;110:467–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12202036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai ZC, et al.  Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell. 2005;120:675–685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15766530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122:421–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16096061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell. 2006;126:767–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16923395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei X, Shimizu T, Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 2007;26:1772–1781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1847660</ArticleId>
            <ArticleId IdType="pubmed">17347649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Liu Y, Zheng Y, Dong J, Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell. 2008;14:388–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18258486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, et al.  Identification of Happyhour/MAP4K as alternative Hpo/Mst-like kinases in the Hippo kinase cascade. Dev Cell. 2015;34:642–655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4589524</ArticleId>
            <ArticleId IdType="pubmed">26364751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, et al.  The conserved misshapen–warts–Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell. 2014;31:291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4254555</ArticleId>
            <ArticleId IdType="pubmed">25453828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, et al.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4600732</ArticleId>
            <ArticleId IdType="pubmed">26437443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staley BK, Irvine KD. Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol. 2010;20:1580–1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2955330</ArticleId>
            <ArticleId IdType="pubmed">20727758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27:355–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3589553</ArticleId>
            <ArticleId IdType="pubmed">23431053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei QY, et al.  TAZ promotes cell proliferation and epithelial–mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol. 2008;28:2426–2436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268418</ArticleId>
            <ArticleId IdType="pubmed">18227151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141:1614–1626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24715453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glantschnig H, Rodan GA, Reszka AA. Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem. 2002;277:42987–42996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12223493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KK, Yonehara S. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST) J Biol Chem. 2002;277:12351–12358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11805089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creasy CL, Ambrose DM, Chernoff J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J Biol Chem. 1996;271:21049–21053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8702870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang E, et al.  Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA. 2007;104:9236–9241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1890478</ArticleId>
            <ArticleId IdType="pubmed">17517604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni L, Zheng Y, Hara M, Pan D, Luo X. Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling. Genes Dev. 2015;29:1416–1431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4511216</ArticleId>
            <ArticleId IdType="pubmed">26108669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Callus BA, Verhagen AM, Vaux DL. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006;273:4264–4276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16930133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan EH, et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076–2086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15688006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747–2761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2045129</ArticleId>
            <ArticleId IdType="pubmed">17974916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 2010;24:72–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2802193</ArticleId>
            <ArticleId IdType="pubmed">20048001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22:1962–1971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2492741</ArticleId>
            <ArticleId IdType="pubmed">18579750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J, et al.  Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666353</ArticleId>
            <ArticleId IdType="pubmed">17889654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami H, et al.  LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71:873–883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21245096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med. 2015;21:212–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4385444</ArticleId>
            <ArticleId IdType="pubmed">25702974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13:63–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4167640</ArticleId>
            <ArticleId IdType="pubmed">24336504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulzke JD, et al.  Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 2009;1165:294–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19538319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paramasivam M, Sarkeshik A, Yates JR, 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725–3733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3183025</ArticleId>
            <ArticleId IdType="pubmed">21832154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3012936</ArticleId>
            <ArticleId IdType="pubmed">21205866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, et al.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell. 2010;18:288–299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2858562</ArticleId>
            <ArticleId IdType="pubmed">20159598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell. 2010;18:300–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2845807</ArticleId>
            <ArticleId IdType="pubmed">20159599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell. 2010;18:309–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20159600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohseni M, et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway. Nat Cell Biol. 2014;16:108–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4159053</ArticleId>
            <ArticleId IdType="pubmed">24362629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, et al.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500–510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380774</ArticleId>
            <ArticleId IdType="pubmed">25751140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, et al.  AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17:490–499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380807</ArticleId>
            <ArticleId IdType="pubmed">25751139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeRan M, et al.  Energy stress regulates hippo–YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9:495–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4223634</ArticleId>
            <ArticleId IdType="pubmed">25373897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol. 2006;16:2101–2110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17045801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho E, et al.  Delineation of a Fat tumor suppressor pathway. Nat Genet. 2006;38:1142–1150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16980976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol. 2006;16:2081–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willecke M, et al.  The Fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol. 2006;16:2090–2100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA. 2011;108:11930–11935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3141988</ArticleId>
            <ArticleId IdType="pubmed">21730131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori M, et al.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156:893–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3982296</ArticleId>
            <ArticleId IdType="pubmed">24581491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. J Biol Chem. 2014;289:1886–1891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3900939</ArticleId>
            <ArticleId IdType="pubmed">24324261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao D, et al.  A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3962829</ArticleId>
            <ArticleId IdType="pubmed">24525530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, et al.  Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat Commun. 2015;6:6239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25695629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, et al.  Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol. 2015;17:95–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25438054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, et al.  Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258966</ArticleId>
            <ArticleId IdType="pubmed">22215811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. Cytoskeletal tension inhibits Hippo signaling through an Ajuba–Warts complex. Cell. 2014;158:143–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4082802</ArticleId>
            <ArticleId IdType="pubmed">24995985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Codelia VA, Sun G, Irvine KD. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol. 2014;24:2012–2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4160395</ArticleId>
            <ArticleId IdType="pubmed">25127217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gayer CP, Basson MD. The effects of mechanical forces on intestinal physiology and pathology. Cell Signal. 2009;21:1237–1244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2715958</ArticleId>
            <ArticleId IdType="pubmed">19249356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Regulation of the Hippo–YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3433174</ArticleId>
            <ArticleId IdType="pubmed">22863277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 2013;27:1223–1232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690396</ArticleId>
            <ArticleId IdType="pubmed">23752589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs) Genes Dev. 2012;26:2138–2143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3465735</ArticleId>
            <ArticleId IdType="pubmed">22972936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Hayre M, et al.  The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer. 2013;13:412–424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4068741</ArticleId>
            <ArticleId IdType="pubmed">23640210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu G, et al.  Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene. 2014;34:3536–3546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4721508</ArticleId>
            <ArticleId IdType="pubmed">25195862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng X, et al.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014;25:831–845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4074519</ArticleId>
            <ArticleId IdType="pubmed">24882515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 2014;25:822–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4075337</ArticleId>
            <ArticleId IdType="pubmed">24882516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao Y, et al.  A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J Biochem. 2011;150:199–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21586534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iglesias-Bartolome R, et al.  Inactivation of a Gαs-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol. 2015;17:793–803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449815</ArticleId>
            <ArticleId IdType="pubmed">25961504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012;15:421–431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22482725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasco MY, Loudhaief R, Gallet A. The cellular homeostasis of the gut: what the Drosophila model points out. Histol Histopathol. 2015;30:277–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchon N, Broderick NA, Lemaitre B. Gut homeostasis in a microbial world: insights from Drosophila melanogaster. Nat Rev Microbiol. 2013;11:615–626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23893105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Ajuba family proteins link JNK to Hippo signaling. Sci Signal. 2013;6:ra81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3830546</ArticleId>
            <ArticleId IdType="pubmed">24023255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw RL, et al.  The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development. 2010;137:4147–4158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990206</ArticleId>
            <ArticleId IdType="pubmed">21068063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karpowicz P, Perez J, Perrimon N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development. 2010;137:4135–4145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990205</ArticleId>
            <ArticleId IdType="pubmed">21098564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA. 2010;107:21064–21069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3000252</ArticleId>
            <ArticleId IdType="pubmed">21078993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, et al.  Bantam is essential for Drosophila intestinal stem cell proliferation in response to Hippo signaling. Dev Biol. 2014;385:211–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24262985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol. 2012;22:389–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22305752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, et al.  Suppressor of Deltex mediates Pez degradation and modulates Drosophila midgut homeostasis. Nat Commun. 2015;6:6607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25814387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, et al.  Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science. 2004;304:1164–1166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15155950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang X, et al.  The sterile 20-like kinase tao controls tissue homeostasis by regulating the hippo pathway in Drosophila adult midgut. J Genet Genomics. 2014;41:429–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25160975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration. Cell Res. 2013;23:1133–1146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3760623</ArticleId>
            <ArticleId IdType="pubmed">23896988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, et al.  Brahma is essential for Drosophila intestinal stem cell proliferation and regulated by Hippo signaling. eLife. 2013;2:e00999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3796317</ArticleId>
            <ArticleId IdType="pubmed">24137538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24326621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato T, et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3547360</ArticleId>
            <ArticleId IdType="pubmed">21113151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz J, et al.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. EMBO J. 2012;31:3079–3091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3400017</ArticleId>
            <ArticleId IdType="pubmed">22692129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian H, et al.  A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 2011;478:255–259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4251967</ArticleId>
            <ArticleId IdType="pubmed">21927002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642–656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4197875</ArticleId>
            <ArticleId IdType="pubmed">24825474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camargo FD, et al.  YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054–2060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17980593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157–170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24976009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, et al.  The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010;24:2383–2388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964748</ArticleId>
            <ArticleId IdType="pubmed">21041407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA. 2011;108:E1312–E1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3241824</ArticleId>
            <ArticleId IdType="pubmed">22042863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Ebisuya M, Nishida E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol. 2015;17:7–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25531778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llado V, et al.  Repression of intestinal stem cell function and tumorigenesis through direct phosphorylation of β-catenin and Yap by PKCζ. Cell Rep. 2015;10:740–754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4524805</ArticleId>
            <ArticleId IdType="pubmed">25660024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barry ER, et al.  Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3536889</ArticleId>
            <ArticleId IdType="pubmed">23178811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, et al.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 2015;29:1271–1284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495398</ArticleId>
            <ArticleId IdType="pubmed">26109050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, et al.  Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev. 2015;29:1285–1297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495399</ArticleId>
            <ArticleId IdType="pubmed">26109051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai X, et al.  YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 2015;25:1175–1178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4650621</ArticleId>
            <ArticleId IdType="pubmed">26315483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi K, et al.  A gp130–Src–YAP module links inflammation to epithelial regeneration. Nature. 2015;519:57–U107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4447318</ArticleId>
            <ArticleId IdType="pubmed">25731159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature. 2015;526:715–718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26503053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroncek JD, Reichert WM.  Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. CRC Press; 2008. </Citation>
        </Reference>
        <Reference>
          <Citation>Vanuytsel T, Senger S, Fasano A, Shea-Donohue T. Major signaling pathways in intestinal stem cells. Biochim Biophys Acta. 2013;1830:2410–2426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4408610</ArticleId>
            <ArticleId IdType="pubmed">22922290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003;17:1709–1713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC196179</ArticleId>
            <ArticleId IdType="pubmed">12865297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batlle E, et al.  β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002;111:251–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12408869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korinek V, et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379–383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9697701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X, et al.  The Hippo pathway regulates Wnt/β-catenin signaling. Dev Cell. 2010;18:579–591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20412773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J. 2012;31:1109–1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3297994</ArticleId>
            <ArticleId IdType="pubmed">22234184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  Role of TAZ as mediator of Wnt signaling. Cell. 2012;151:1443–1456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konsavage WM, et al.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem. 2012;287:11730–11739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3320921</ArticleId>
            <ArticleId IdType="pubmed">22337891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338:108–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3706630</ArticleId>
            <ArticleId IdType="pubmed">22956684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HW, et al.  Alternative Wnt signaling activates YAP/TAZ. Cell. 2015;162:780–794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4538707</ArticleId>
            <ArticleId IdType="pubmed">26276632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanDussen KL, et al.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development. 2012;139:488–497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3252352</ArticleId>
            <ArticleId IdType="pubmed">22190634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, Cremona CA, Behrens A. Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease. EMBO Rep. 2015;16:571–581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4428041</ArticleId>
            <ArticleId IdType="pubmed">25855643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Es JH, et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15959515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yimlamai D, et al.  Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324–1338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4136468</ArticleId>
            <ArticleId IdType="pubmed">24906150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang RN, et al.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1:87–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4232216</ArticleId>
            <ArticleId IdType="pubmed">25401122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haramis AP, et al.  De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303:1684–1686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15017003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XC, et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet. 2004;36:1117–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15378062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C, et al.  Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell. 2009;139:757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batts LE, Polk DB, Dubois RN, Kulessa H. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn. 2006;235:1563–1570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16538672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosinski C, et al.  Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology. 2010;139:893–903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2930094</ArticleId>
            <ArticleId IdType="pubmed">20542037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reifenberger J, et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1998;58:1798–1803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9581815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev. 2003;13:34–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12573433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez LA, et al.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009;23:2729–2741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2788333</ArticleId>
            <ArticleId IdType="pubmed">19952108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:2101–2114.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20420949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, et al.  NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol. 2015;25:296–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4426889</ArticleId>
            <ArticleId IdType="pubmed">25601544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhardt AA, et al.  Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008;39:1582–1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720436</ArticleId>
            <ArticleId IdType="pubmed">18703216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam-Himlin DM, et al.  The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer. 2006;37:103–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18175224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, et al.  Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS ONE. 2013;8:e65539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677905</ArticleId>
            <ArticleId IdType="pubmed">23762387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuen HF, et al.  TAZ expression as a prognostic indicator in colorectal cancer. PLoS ONE. 2013;8:e54211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3553150</ArticleId>
            <ArticleId IdType="pubmed">23372686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan J, et al.  Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo. Oncol Rep. 2012;28:179–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22470139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powell SM, et al.  APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1528264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000;103:311–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11057903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–1038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1867011</ArticleId>
            <ArticleId IdType="pubmed">10514384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawford HC, et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 1999;18:2883–2891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10362259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, et al.  Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–1512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9727977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10201372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, Chan TA, Vogelstein B, Kinzler KW. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999;99:335–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3779681</ArticleId>
            <ArticleId IdType="pubmed">10555149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, Maitra A, Anders RA, Taketo MM, Pan D. β-catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015;29:1493–1506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526734</ArticleId>
            <ArticleId IdType="pubmed">26193883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenbluh J, et al.  β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151:1457–1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3530160</ArticleId>
            <ArticleId IdType="pubmed">23245941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, et al.  JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 2009;28:1843–1854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2711188</ArticleId>
            <ArticleId IdType="pubmed">19521338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012;72:379–386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3261582</ArticleId>
            <ArticleId IdType="pubmed">22253282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol. 2011;350:139–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3038240</ArticleId>
            <ArticleId IdType="pubmed">21145886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomlinson V, et al.  JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010;1:e29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3032333</ArticleId>
            <ArticleId IdType="pubmed">21364637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehenni H, et al.  Loss of LKB1 kinase activity in Peutz–Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet. 1998;63:1641–1650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1377635</ArticleId>
            <ArticleId IdType="pubmed">9837816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giardiello FM, et al.  Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med. 1987;316:1511–1514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3587280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz–Jeghers syndrome. Oncogene. 2007;26:7825–7832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17599048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HB, Babcock JT, Wells CD, Quilliam LA. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene. 2013;32:4100–4109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3977597</ArticleId>
            <ArticleId IdType="pubmed">23027127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grivennikov S, et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2667107</ArticleId>
            <ArticleId IdType="pubmed">19185845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bechmann LP, et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–964.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22173168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836–847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15459664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–S53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16447274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21:886–897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17437995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu MZ, et al.  Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer. 2009;115:4576–4585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2811690</ArticleId>
            <ArticleId IdType="pubmed">19551889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KP, et al.  The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA. 2010;107:8248–8253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2889558</ArticleId>
            <ArticleId IdType="pubmed">20404163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16:425–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3023165</ArticleId>
            <ArticleId IdType="pubmed">19878874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song H, et al.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA. 2010;107:1431–1436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824397</ArticleId>
            <ArticleId IdType="pubmed">20080598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu L, et al.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA. 2010;107:1437–1442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824398</ArticleId>
            <ArticleId IdType="pubmed">20080689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, et al.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19:27–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2925178</ArticleId>
            <ArticleId IdType="pubmed">20643348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin F, et al.  Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell. 2013;154:1342–1355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3835333</ArticleId>
            <ArticleId IdType="pubmed">24012335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishio M, et al.  Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest. 2012;122:4505–4518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3533542</ArticleId>
            <ArticleId IdType="pubmed">23143302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Septer S, et al.  Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol. 2012;302:G493–G503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3311431</ArticleId>
            <ArticleId IdType="pubmed">22194415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poncy A, et al.  Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26033091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grijalva JL, et al.  Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307:G196–G204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24875096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte U, et al.  Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009;50:844–851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2914599</ArticleId>
            <ArticleId IdType="pubmed">19575460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herr KJ, et al.  Loss of α-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep. 2014;4:6835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213774</ArticleId>
            <ArticleId IdType="pubmed">25355493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su T, et al.  Two-signal requirement for growth-promoting function of Yap in hepatocytes. eLife. 2015;4:e02948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4363878</ArticleId>
            <ArticleId IdType="pubmed">25667983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mannaerts I, et al.  The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol. 2015;63:679–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25908270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai H, et al.  Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol. 2012;43:1376–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3384990</ArticleId>
            <ArticleId IdType="pubmed">22436626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, et al.  Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102–10115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4496343</ArticleId>
            <ArticleId IdType="pubmed">25826091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, et al.  Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int. 2012;32:38–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4175712</ArticleId>
            <ArticleId IdType="pubmed">22098159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahn EY, Kim JS, Kim GJ, Park YN. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol Cancer Res. 2013;11:748–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23594797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohn BH, et al.  Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma. Clin Cancer Res. 2016;22:1256–1264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5536176</ArticleId>
            <ArticleId IdType="pubmed">26459179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zender L, et al.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006;125:1253–1267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3026384</ArticleId>
            <ArticleId IdType="pubmed">16814713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowalik MA, et al.  Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology. 2011;53:2086–2096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21391223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, et al.  Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 2005;19:1646–1653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15831521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong B, et al.  Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun. 2015;6:5944.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4324535</ArticleId>
            <ArticleId IdType="pubmed">25661872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, et al.  Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012;56:2051–2059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22707013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu P, et al.  HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma. Oncotarget. 2015;6:29048–29059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4745710</ArticleId>
            <ArticleId IdType="pubmed">26315112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, et al.  Bile acid receptors and liver cancer. Curr Pathobiol Rep. 2013;1:29–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3571718</ArticleId>
            <ArticleId IdType="pubmed">23420103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu N, et al.  Hepatocarcinogenesis in FXR−/− mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. Mol Endocrinol. 2012;26:775–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3355555</ArticleId>
            <ArticleId IdType="pubmed">22474109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anakk S, et al.  Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 2013;5:1060–1069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3961013</ArticleId>
            <ArticleId IdType="pubmed">24268772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park YY, et al.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology. 2015;63:159–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4881866</ArticleId>
            <ArticleId IdType="pubmed">26389641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tschaharganeh DF, et al.  Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology. 2013;144:1530–1542.e12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3665638</ArticleId>
            <ArticleId IdType="pubmed">23419361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen S, et al.  A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 2015;25:997–1012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559818</ArticleId>
            <ArticleId IdType="pubmed">26272168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitamant J, et al.  YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep. 2015;10:1692–1707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4565791</ArticleId>
            <ArticleId IdType="pubmed">25772357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu-Chittenden Y, et al.  Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300–1305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3387657</ArticleId>
            <ArticleId IdType="pubmed">22677547</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27147489</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-5053</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Gastroenterology &amp; hepatology</Title>
          <ISOAbbreviation>Nat Rev Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Hippo pathway in intestinal regeneration and disease.</ArticleTitle>
        <Pagination>
          <StartPage>324</StartPage>
          <EndPage>337</EndPage>
          <MedlinePgn>324-37</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrgastro.2016.59</ELocationID>
        <Abstract>
          <AbstractText>The Hippo pathway is a signalling cascade conserved from Drosophila melanogaster to mammals. The mammalian core kinase components comprise MST1 and MST2, SAV1, LATS1 and LATS2 and MOB1A and MOB1B. The transcriptional co-activators YAP1 and TAZ are the downstream effectors of the Hippo pathway and regulate target gene expression. Hippo signalling has crucial roles in the control of organ size, tissue homeostasis and regeneration, and dysregulation of the Hippo pathway can lead to uncontrolled cell growth and malignant transformation. Mammalian intestine consists of a stem cell compartment as well as differentiated cells, and its ability to regenerate rapidly after injury makes it an excellent model system to study tissue homeostasis, regeneration and tumorigenesis. Several studies have established the important role of the Hippo pathway in these processes. In addition, crosstalk between Hippo and other signalling pathways provides tight, yet versatile, regulation of tissue homeostasis. In this Review, we summarize studies on the role of the Hippo pathway in the intestine on these physiological processes and the underlying mechanisms responsible, and discuss future research directions and potential therapeutic strategies targeting Hippo signalling in intestinal disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Audrey W</ForeName>
            <Initials>AW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Zhipeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Kun-Liang</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 CA023100</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA132809</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R35 CA196878</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 GM007752</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>101500079</NlmUniqueID>
        <ISSNLinking>1759-5045</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000091102">YAP-Signaling Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C088374">YAP1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.-</RegistryNumber>
          <NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.-</RegistryNumber>
          <NameOfSubstance UI="C108675">TAFAZZIN protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000217" MajorTopicYN="N">Acyltransferases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007420" MajorTopicYN="N">Intestine, Large</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012038" MajorTopicYN="N">Regeneration</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091102" MajorTopicYN="N">YAP-Signaling Proteins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests statement</b>. The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27147489</ArticleId>
        <ArticleId IdType="mid">NIHMS874810</ArticleId>
        <ArticleId IdType="pmc">PMC5642988</ArticleId>
        <ArticleId IdType="doi">10.1038/nrgastro.2016.59</ArticleId>
        <ArticleId IdType="pii">nrgastro.2016.59</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barry ER, Camargo FD. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol. 2013;25:247–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23312716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94:1287–1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25287865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246–257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23467301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4562315</ArticleId>
            <ArticleId IdType="pubmed">25592648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Meng Z, Plouffe SW, Guan KL. Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol. 2015;77:201–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossuyt W, et al.  An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene. 2014;33:1218–1228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4613760</ArticleId>
            <ArticleId IdType="pubmed">23563179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4701972</ArticleId>
            <ArticleId IdType="pubmed">26728553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9:534–546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7698644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7743921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003;114:445–456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003;5:914–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol. 2003;5:921–927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia J, Zhang W, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 2003;17:2514–2519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC218145</ArticleId>
            <ArticleId IdType="pubmed">14561774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003;114:457–467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kango-Singh M, et al.  Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development. 2002;129:5719–5730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12421711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapon N, et al.  salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002;110:467–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12202036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai ZC, et al.  Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell. 2005;120:675–685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15766530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122:421–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16096061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell. 2006;126:767–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16923395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei X, Shimizu T, Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 2007;26:1772–1781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1847660</ArticleId>
            <ArticleId IdType="pubmed">17347649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Liu Y, Zheng Y, Dong J, Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell. 2008;14:388–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18258486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, et al.  Identification of Happyhour/MAP4K as alternative Hpo/Mst-like kinases in the Hippo kinase cascade. Dev Cell. 2015;34:642–655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4589524</ArticleId>
            <ArticleId IdType="pubmed">26364751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, et al.  The conserved misshapen–warts–Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell. 2014;31:291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4254555</ArticleId>
            <ArticleId IdType="pubmed">25453828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, et al.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4600732</ArticleId>
            <ArticleId IdType="pubmed">26437443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staley BK, Irvine KD. Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol. 2010;20:1580–1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2955330</ArticleId>
            <ArticleId IdType="pubmed">20727758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27:355–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3589553</ArticleId>
            <ArticleId IdType="pubmed">23431053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei QY, et al.  TAZ promotes cell proliferation and epithelial–mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol. 2008;28:2426–2436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268418</ArticleId>
            <ArticleId IdType="pubmed">18227151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141:1614–1626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24715453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glantschnig H, Rodan GA, Reszka AA. Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem. 2002;277:42987–42996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12223493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KK, Yonehara S. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST) J Biol Chem. 2002;277:12351–12358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11805089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creasy CL, Ambrose DM, Chernoff J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J Biol Chem. 1996;271:21049–21053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8702870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang E, et al.  Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA. 2007;104:9236–9241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1890478</ArticleId>
            <ArticleId IdType="pubmed">17517604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni L, Zheng Y, Hara M, Pan D, Luo X. Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling. Genes Dev. 2015;29:1416–1431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4511216</ArticleId>
            <ArticleId IdType="pubmed">26108669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Callus BA, Verhagen AM, Vaux DL. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006;273:4264–4276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16930133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan EH, et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076–2086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15688006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747–2761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2045129</ArticleId>
            <ArticleId IdType="pubmed">17974916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 2010;24:72–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2802193</ArticleId>
            <ArticleId IdType="pubmed">20048001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22:1962–1971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2492741</ArticleId>
            <ArticleId IdType="pubmed">18579750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J, et al.  Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666353</ArticleId>
            <ArticleId IdType="pubmed">17889654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami H, et al.  LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71:873–883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21245096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med. 2015;21:212–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4385444</ArticleId>
            <ArticleId IdType="pubmed">25702974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13:63–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4167640</ArticleId>
            <ArticleId IdType="pubmed">24336504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulzke JD, et al.  Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 2009;1165:294–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19538319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paramasivam M, Sarkeshik A, Yates JR, 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725–3733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3183025</ArticleId>
            <ArticleId IdType="pubmed">21832154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3012936</ArticleId>
            <ArticleId IdType="pubmed">21205866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, et al.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell. 2010;18:288–299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2858562</ArticleId>
            <ArticleId IdType="pubmed">20159598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell. 2010;18:300–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2845807</ArticleId>
            <ArticleId IdType="pubmed">20159599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell. 2010;18:309–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20159600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohseni M, et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway. Nat Cell Biol. 2014;16:108–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4159053</ArticleId>
            <ArticleId IdType="pubmed">24362629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, et al.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500–510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380774</ArticleId>
            <ArticleId IdType="pubmed">25751140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, et al.  AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17:490–499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380807</ArticleId>
            <ArticleId IdType="pubmed">25751139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeRan M, et al.  Energy stress regulates hippo–YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9:495–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4223634</ArticleId>
            <ArticleId IdType="pubmed">25373897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol. 2006;16:2101–2110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17045801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho E, et al.  Delineation of a Fat tumor suppressor pathway. Nat Genet. 2006;38:1142–1150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16980976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol. 2006;16:2081–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willecke M, et al.  The Fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol. 2006;16:2090–2100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA. 2011;108:11930–11935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3141988</ArticleId>
            <ArticleId IdType="pubmed">21730131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori M, et al.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156:893–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3982296</ArticleId>
            <ArticleId IdType="pubmed">24581491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. J Biol Chem. 2014;289:1886–1891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3900939</ArticleId>
            <ArticleId IdType="pubmed">24324261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao D, et al.  A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3962829</ArticleId>
            <ArticleId IdType="pubmed">24525530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, et al.  Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat Commun. 2015;6:6239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25695629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, et al.  Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol. 2015;17:95–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25438054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, et al.  Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258966</ArticleId>
            <ArticleId IdType="pubmed">22215811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. Cytoskeletal tension inhibits Hippo signaling through an Ajuba–Warts complex. Cell. 2014;158:143–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4082802</ArticleId>
            <ArticleId IdType="pubmed">24995985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Codelia VA, Sun G, Irvine KD. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol. 2014;24:2012–2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4160395</ArticleId>
            <ArticleId IdType="pubmed">25127217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gayer CP, Basson MD. The effects of mechanical forces on intestinal physiology and pathology. Cell Signal. 2009;21:1237–1244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2715958</ArticleId>
            <ArticleId IdType="pubmed">19249356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Regulation of the Hippo–YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3433174</ArticleId>
            <ArticleId IdType="pubmed">22863277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 2013;27:1223–1232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690396</ArticleId>
            <ArticleId IdType="pubmed">23752589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs) Genes Dev. 2012;26:2138–2143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3465735</ArticleId>
            <ArticleId IdType="pubmed">22972936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Hayre M, et al.  The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer. 2013;13:412–424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4068741</ArticleId>
            <ArticleId IdType="pubmed">23640210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu G, et al.  Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene. 2014;34:3536–3546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4721508</ArticleId>
            <ArticleId IdType="pubmed">25195862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng X, et al.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014;25:831–845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4074519</ArticleId>
            <ArticleId IdType="pubmed">24882515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 2014;25:822–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4075337</ArticleId>
            <ArticleId IdType="pubmed">24882516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao Y, et al.  A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J Biochem. 2011;150:199–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21586534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iglesias-Bartolome R, et al.  Inactivation of a Gαs-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol. 2015;17:793–803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449815</ArticleId>
            <ArticleId IdType="pubmed">25961504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012;15:421–431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22482725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasco MY, Loudhaief R, Gallet A. The cellular homeostasis of the gut: what the Drosophila model points out. Histol Histopathol. 2015;30:277–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchon N, Broderick NA, Lemaitre B. Gut homeostasis in a microbial world: insights from Drosophila melanogaster. Nat Rev Microbiol. 2013;11:615–626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23893105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Ajuba family proteins link JNK to Hippo signaling. Sci Signal. 2013;6:ra81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3830546</ArticleId>
            <ArticleId IdType="pubmed">24023255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw RL, et al.  The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development. 2010;137:4147–4158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990206</ArticleId>
            <ArticleId IdType="pubmed">21068063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karpowicz P, Perez J, Perrimon N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development. 2010;137:4135–4145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990205</ArticleId>
            <ArticleId IdType="pubmed">21098564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA. 2010;107:21064–21069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3000252</ArticleId>
            <ArticleId IdType="pubmed">21078993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, et al.  Bantam is essential for Drosophila intestinal stem cell proliferation in response to Hippo signaling. Dev Biol. 2014;385:211–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24262985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol. 2012;22:389–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22305752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, et al.  Suppressor of Deltex mediates Pez degradation and modulates Drosophila midgut homeostasis. Nat Commun. 2015;6:6607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25814387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, et al.  Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science. 2004;304:1164–1166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15155950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang X, et al.  The sterile 20-like kinase tao controls tissue homeostasis by regulating the hippo pathway in Drosophila adult midgut. J Genet Genomics. 2014;41:429–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25160975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration. Cell Res. 2013;23:1133–1146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3760623</ArticleId>
            <ArticleId IdType="pubmed">23896988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, et al.  Brahma is essential for Drosophila intestinal stem cell proliferation and regulated by Hippo signaling. eLife. 2013;2:e00999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3796317</ArticleId>
            <ArticleId IdType="pubmed">24137538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24326621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato T, et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3547360</ArticleId>
            <ArticleId IdType="pubmed">21113151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz J, et al.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. EMBO J. 2012;31:3079–3091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3400017</ArticleId>
            <ArticleId IdType="pubmed">22692129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian H, et al.  A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 2011;478:255–259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4251967</ArticleId>
            <ArticleId IdType="pubmed">21927002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642–656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4197875</ArticleId>
            <ArticleId IdType="pubmed">24825474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camargo FD, et al.  YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054–2060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17980593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157–170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24976009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, et al.  The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010;24:2383–2388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964748</ArticleId>
            <ArticleId IdType="pubmed">21041407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA. 2011;108:E1312–E1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3241824</ArticleId>
            <ArticleId IdType="pubmed">22042863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Ebisuya M, Nishida E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol. 2015;17:7–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25531778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llado V, et al.  Repression of intestinal stem cell function and tumorigenesis through direct phosphorylation of β-catenin and Yap by PKCζ. Cell Rep. 2015;10:740–754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4524805</ArticleId>
            <ArticleId IdType="pubmed">25660024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barry ER, et al.  Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3536889</ArticleId>
            <ArticleId IdType="pubmed">23178811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, et al.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 2015;29:1271–1284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495398</ArticleId>
            <ArticleId IdType="pubmed">26109050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, et al.  Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev. 2015;29:1285–1297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495399</ArticleId>
            <ArticleId IdType="pubmed">26109051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai X, et al.  YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 2015;25:1175–1178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4650621</ArticleId>
            <ArticleId IdType="pubmed">26315483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi K, et al.  A gp130–Src–YAP module links inflammation to epithelial regeneration. Nature. 2015;519:57–U107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4447318</ArticleId>
            <ArticleId IdType="pubmed">25731159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature. 2015;526:715–718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26503053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroncek JD, Reichert WM.  Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. CRC Press; 2008. </Citation>
        </Reference>
        <Reference>
          <Citation>Vanuytsel T, Senger S, Fasano A, Shea-Donohue T. Major signaling pathways in intestinal stem cells. Biochim Biophys Acta. 2013;1830:2410–2426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4408610</ArticleId>
            <ArticleId IdType="pubmed">22922290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003;17:1709–1713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC196179</ArticleId>
            <ArticleId IdType="pubmed">12865297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batlle E, et al.  β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002;111:251–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12408869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korinek V, et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379–383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9697701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X, et al.  The Hippo pathway regulates Wnt/β-catenin signaling. Dev Cell. 2010;18:579–591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20412773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J. 2012;31:1109–1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3297994</ArticleId>
            <ArticleId IdType="pubmed">22234184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  Role of TAZ as mediator of Wnt signaling. Cell. 2012;151:1443–1456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konsavage WM, et al.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem. 2012;287:11730–11739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3320921</ArticleId>
            <ArticleId IdType="pubmed">22337891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338:108–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3706630</ArticleId>
            <ArticleId IdType="pubmed">22956684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HW, et al.  Alternative Wnt signaling activates YAP/TAZ. Cell. 2015;162:780–794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4538707</ArticleId>
            <ArticleId IdType="pubmed">26276632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanDussen KL, et al.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development. 2012;139:488–497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3252352</ArticleId>
            <ArticleId IdType="pubmed">22190634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, Cremona CA, Behrens A. Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease. EMBO Rep. 2015;16:571–581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4428041</ArticleId>
            <ArticleId IdType="pubmed">25855643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Es JH, et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15959515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yimlamai D, et al.  Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324–1338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4136468</ArticleId>
            <ArticleId IdType="pubmed">24906150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang RN, et al.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1:87–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4232216</ArticleId>
            <ArticleId IdType="pubmed">25401122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haramis AP, et al.  De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303:1684–1686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15017003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XC, et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet. 2004;36:1117–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15378062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C, et al.  Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell. 2009;139:757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batts LE, Polk DB, Dubois RN, Kulessa H. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn. 2006;235:1563–1570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16538672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosinski C, et al.  Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology. 2010;139:893–903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2930094</ArticleId>
            <ArticleId IdType="pubmed">20542037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reifenberger J, et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1998;58:1798–1803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9581815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev. 2003;13:34–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12573433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez LA, et al.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009;23:2729–2741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2788333</ArticleId>
            <ArticleId IdType="pubmed">19952108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:2101–2114.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20420949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, et al.  NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol. 2015;25:296–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4426889</ArticleId>
            <ArticleId IdType="pubmed">25601544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhardt AA, et al.  Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008;39:1582–1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720436</ArticleId>
            <ArticleId IdType="pubmed">18703216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam-Himlin DM, et al.  The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer. 2006;37:103–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18175224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, et al.  Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS ONE. 2013;8:e65539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677905</ArticleId>
            <ArticleId IdType="pubmed">23762387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuen HF, et al.  TAZ expression as a prognostic indicator in colorectal cancer. PLoS ONE. 2013;8:e54211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3553150</ArticleId>
            <ArticleId IdType="pubmed">23372686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan J, et al.  Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo. Oncol Rep. 2012;28:179–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22470139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powell SM, et al.  APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1528264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000;103:311–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11057903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–1038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1867011</ArticleId>
            <ArticleId IdType="pubmed">10514384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawford HC, et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 1999;18:2883–2891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10362259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, et al.  Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–1512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9727977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10201372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, Chan TA, Vogelstein B, Kinzler KW. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999;99:335–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3779681</ArticleId>
            <ArticleId IdType="pubmed">10555149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, Maitra A, Anders RA, Taketo MM, Pan D. β-catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015;29:1493–1506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526734</ArticleId>
            <ArticleId IdType="pubmed">26193883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenbluh J, et al.  β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151:1457–1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3530160</ArticleId>
            <ArticleId IdType="pubmed">23245941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, et al.  JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 2009;28:1843–1854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2711188</ArticleId>
            <ArticleId IdType="pubmed">19521338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012;72:379–386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3261582</ArticleId>
            <ArticleId IdType="pubmed">22253282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol. 2011;350:139–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3038240</ArticleId>
            <ArticleId IdType="pubmed">21145886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomlinson V, et al.  JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010;1:e29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3032333</ArticleId>
            <ArticleId IdType="pubmed">21364637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehenni H, et al.  Loss of LKB1 kinase activity in Peutz–Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet. 1998;63:1641–1650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1377635</ArticleId>
            <ArticleId IdType="pubmed">9837816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giardiello FM, et al.  Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med. 1987;316:1511–1514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3587280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz–Jeghers syndrome. Oncogene. 2007;26:7825–7832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17599048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HB, Babcock JT, Wells CD, Quilliam LA. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene. 2013;32:4100–4109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3977597</ArticleId>
            <ArticleId IdType="pubmed">23027127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grivennikov S, et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2667107</ArticleId>
            <ArticleId IdType="pubmed">19185845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bechmann LP, et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–964.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22173168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836–847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15459664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–S53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16447274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21:886–897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17437995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu MZ, et al.  Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer. 2009;115:4576–4585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2811690</ArticleId>
            <ArticleId IdType="pubmed">19551889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KP, et al.  The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA. 2010;107:8248–8253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2889558</ArticleId>
            <ArticleId IdType="pubmed">20404163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16:425–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3023165</ArticleId>
            <ArticleId IdType="pubmed">19878874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song H, et al.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA. 2010;107:1431–1436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824397</ArticleId>
            <ArticleId IdType="pubmed">20080598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu L, et al.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA. 2010;107:1437–1442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824398</ArticleId>
            <ArticleId IdType="pubmed">20080689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, et al.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19:27–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2925178</ArticleId>
            <ArticleId IdType="pubmed">20643348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin F, et al.  Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell. 2013;154:1342–1355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3835333</ArticleId>
            <ArticleId IdType="pubmed">24012335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishio M, et al.  Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest. 2012;122:4505–4518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3533542</ArticleId>
            <ArticleId IdType="pubmed">23143302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Septer S, et al.  Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol. 2012;302:G493–G503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3311431</ArticleId>
            <ArticleId IdType="pubmed">22194415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poncy A, et al.  Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26033091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grijalva JL, et al.  Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307:G196–G204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24875096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte U, et al.  Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009;50:844–851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2914599</ArticleId>
            <ArticleId IdType="pubmed">19575460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herr KJ, et al.  Loss of α-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep. 2014;4:6835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213774</ArticleId>
            <ArticleId IdType="pubmed">25355493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su T, et al.  Two-signal requirement for growth-promoting function of Yap in hepatocytes. eLife. 2015;4:e02948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4363878</ArticleId>
            <ArticleId IdType="pubmed">25667983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mannaerts I, et al.  The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol. 2015;63:679–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25908270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai H, et al.  Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol. 2012;43:1376–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3384990</ArticleId>
            <ArticleId IdType="pubmed">22436626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, et al.  Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102–10115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4496343</ArticleId>
            <ArticleId IdType="pubmed">25826091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, et al.  Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int. 2012;32:38–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4175712</ArticleId>
            <ArticleId IdType="pubmed">22098159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahn EY, Kim JS, Kim GJ, Park YN. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol Cancer Res. 2013;11:748–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23594797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohn BH, et al.  Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma. Clin Cancer Res. 2016;22:1256–1264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5536176</ArticleId>
            <ArticleId IdType="pubmed">26459179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zender L, et al.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006;125:1253–1267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3026384</ArticleId>
            <ArticleId IdType="pubmed">16814713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowalik MA, et al.  Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology. 2011;53:2086–2096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21391223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, et al.  Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 2005;19:1646–1653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15831521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong B, et al.  Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun. 2015;6:5944.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4324535</ArticleId>
            <ArticleId IdType="pubmed">25661872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, et al.  Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012;56:2051–2059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22707013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu P, et al.  HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma. Oncotarget. 2015;6:29048–29059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4745710</ArticleId>
            <ArticleId IdType="pubmed">26315112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, et al.  Bile acid receptors and liver cancer. Curr Pathobiol Rep. 2013;1:29–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3571718</ArticleId>
            <ArticleId IdType="pubmed">23420103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu N, et al.  Hepatocarcinogenesis in FXR−/− mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. Mol Endocrinol. 2012;26:775–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3355555</ArticleId>
            <ArticleId IdType="pubmed">22474109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anakk S, et al.  Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 2013;5:1060–1069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3961013</ArticleId>
            <ArticleId IdType="pubmed">24268772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park YY, et al.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology. 2015;63:159–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4881866</ArticleId>
            <ArticleId IdType="pubmed">26389641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tschaharganeh DF, et al.  Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology. 2013;144:1530–1542.e12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3665638</ArticleId>
            <ArticleId IdType="pubmed">23419361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen S, et al.  A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 2015;25:997–1012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559818</ArticleId>
            <ArticleId IdType="pubmed">26272168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitamant J, et al.  YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep. 2015;10:1692–1707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4565791</ArticleId>
            <ArticleId IdType="pubmed">25772357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu-Chittenden Y, et al.  Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300–1305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3387657</ArticleId>
            <ArticleId IdType="pubmed">22677547</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27147489</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-5053</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Gastroenterology &amp; hepatology</Title>
          <ISOAbbreviation>Nat Rev Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Hippo pathway in intestinal regeneration and disease.</ArticleTitle>
        <Pagination>
          <StartPage>324</StartPage>
          <EndPage>337</EndPage>
          <MedlinePgn>324-37</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrgastro.2016.59</ELocationID>
        <Abstract>
          <AbstractText>The Hippo pathway is a signalling cascade conserved from Drosophila melanogaster to mammals. The mammalian core kinase components comprise MST1 and MST2, SAV1, LATS1 and LATS2 and MOB1A and MOB1B. The transcriptional co-activators YAP1 and TAZ are the downstream effectors of the Hippo pathway and regulate target gene expression. Hippo signalling has crucial roles in the control of organ size, tissue homeostasis and regeneration, and dysregulation of the Hippo pathway can lead to uncontrolled cell growth and malignant transformation. Mammalian intestine consists of a stem cell compartment as well as differentiated cells, and its ability to regenerate rapidly after injury makes it an excellent model system to study tissue homeostasis, regeneration and tumorigenesis. Several studies have established the important role of the Hippo pathway in these processes. In addition, crosstalk between Hippo and other signalling pathways provides tight, yet versatile, regulation of tissue homeostasis. In this Review, we summarize studies on the role of the Hippo pathway in the intestine on these physiological processes and the underlying mechanisms responsible, and discuss future research directions and potential therapeutic strategies targeting Hippo signalling in intestinal disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Audrey W</ForeName>
            <Initials>AW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Zhipeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Kun-Liang</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 CA023100</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA132809</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R35 CA196878</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 GM007752</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>101500079</NlmUniqueID>
        <ISSNLinking>1759-5045</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000091102">YAP-Signaling Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C088374">YAP1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.-</RegistryNumber>
          <NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.-</RegistryNumber>
          <NameOfSubstance UI="C108675">TAFAZZIN protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000217" MajorTopicYN="N">Acyltransferases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007420" MajorTopicYN="N">Intestine, Large</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012038" MajorTopicYN="N">Regeneration</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091102" MajorTopicYN="N">YAP-Signaling Proteins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests statement</b>. The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27147489</ArticleId>
        <ArticleId IdType="mid">NIHMS874810</ArticleId>
        <ArticleId IdType="pmc">PMC5642988</ArticleId>
        <ArticleId IdType="doi">10.1038/nrgastro.2016.59</ArticleId>
        <ArticleId IdType="pii">nrgastro.2016.59</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barry ER, Camargo FD. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol. 2013;25:247–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23312716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94:1287–1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25287865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246–257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23467301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4562315</ArticleId>
            <ArticleId IdType="pubmed">25592648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Meng Z, Plouffe SW, Guan KL. Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol. 2015;77:201–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossuyt W, et al.  An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene. 2014;33:1218–1228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4613760</ArticleId>
            <ArticleId IdType="pubmed">23563179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4701972</ArticleId>
            <ArticleId IdType="pubmed">26728553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9:534–546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7698644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7743921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003;114:445–456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003;5:914–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol. 2003;5:921–927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia J, Zhang W, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 2003;17:2514–2519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC218145</ArticleId>
            <ArticleId IdType="pubmed">14561774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003;114:457–467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kango-Singh M, et al.  Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development. 2002;129:5719–5730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12421711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapon N, et al.  salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002;110:467–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12202036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai ZC, et al.  Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell. 2005;120:675–685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15766530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122:421–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16096061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell. 2006;126:767–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16923395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei X, Shimizu T, Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 2007;26:1772–1781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1847660</ArticleId>
            <ArticleId IdType="pubmed">17347649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Liu Y, Zheng Y, Dong J, Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell. 2008;14:388–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18258486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, et al.  Identification of Happyhour/MAP4K as alternative Hpo/Mst-like kinases in the Hippo kinase cascade. Dev Cell. 2015;34:642–655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4589524</ArticleId>
            <ArticleId IdType="pubmed">26364751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, et al.  The conserved misshapen–warts–Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell. 2014;31:291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4254555</ArticleId>
            <ArticleId IdType="pubmed">25453828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, et al.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4600732</ArticleId>
            <ArticleId IdType="pubmed">26437443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staley BK, Irvine KD. Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol. 2010;20:1580–1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2955330</ArticleId>
            <ArticleId IdType="pubmed">20727758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27:355–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3589553</ArticleId>
            <ArticleId IdType="pubmed">23431053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei QY, et al.  TAZ promotes cell proliferation and epithelial–mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol. 2008;28:2426–2436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268418</ArticleId>
            <ArticleId IdType="pubmed">18227151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141:1614–1626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24715453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glantschnig H, Rodan GA, Reszka AA. Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem. 2002;277:42987–42996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12223493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KK, Yonehara S. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST) J Biol Chem. 2002;277:12351–12358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11805089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creasy CL, Ambrose DM, Chernoff J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J Biol Chem. 1996;271:21049–21053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8702870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang E, et al.  Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA. 2007;104:9236–9241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1890478</ArticleId>
            <ArticleId IdType="pubmed">17517604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni L, Zheng Y, Hara M, Pan D, Luo X. Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling. Genes Dev. 2015;29:1416–1431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4511216</ArticleId>
            <ArticleId IdType="pubmed">26108669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Callus BA, Verhagen AM, Vaux DL. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006;273:4264–4276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16930133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan EH, et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076–2086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15688006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747–2761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2045129</ArticleId>
            <ArticleId IdType="pubmed">17974916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 2010;24:72–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2802193</ArticleId>
            <ArticleId IdType="pubmed">20048001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22:1962–1971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2492741</ArticleId>
            <ArticleId IdType="pubmed">18579750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J, et al.  Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666353</ArticleId>
            <ArticleId IdType="pubmed">17889654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami H, et al.  LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71:873–883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21245096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med. 2015;21:212–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4385444</ArticleId>
            <ArticleId IdType="pubmed">25702974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13:63–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4167640</ArticleId>
            <ArticleId IdType="pubmed">24336504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulzke JD, et al.  Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 2009;1165:294–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19538319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paramasivam M, Sarkeshik A, Yates JR, 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725–3733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3183025</ArticleId>
            <ArticleId IdType="pubmed">21832154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3012936</ArticleId>
            <ArticleId IdType="pubmed">21205866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, et al.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell. 2010;18:288–299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2858562</ArticleId>
            <ArticleId IdType="pubmed">20159598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell. 2010;18:300–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2845807</ArticleId>
            <ArticleId IdType="pubmed">20159599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell. 2010;18:309–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20159600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohseni M, et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway. Nat Cell Biol. 2014;16:108–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4159053</ArticleId>
            <ArticleId IdType="pubmed">24362629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, et al.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500–510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380774</ArticleId>
            <ArticleId IdType="pubmed">25751140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, et al.  AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17:490–499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380807</ArticleId>
            <ArticleId IdType="pubmed">25751139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeRan M, et al.  Energy stress regulates hippo–YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9:495–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4223634</ArticleId>
            <ArticleId IdType="pubmed">25373897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol. 2006;16:2101–2110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17045801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho E, et al.  Delineation of a Fat tumor suppressor pathway. Nat Genet. 2006;38:1142–1150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16980976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol. 2006;16:2081–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willecke M, et al.  The Fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol. 2006;16:2090–2100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA. 2011;108:11930–11935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3141988</ArticleId>
            <ArticleId IdType="pubmed">21730131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori M, et al.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156:893–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3982296</ArticleId>
            <ArticleId IdType="pubmed">24581491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. J Biol Chem. 2014;289:1886–1891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3900939</ArticleId>
            <ArticleId IdType="pubmed">24324261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao D, et al.  A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3962829</ArticleId>
            <ArticleId IdType="pubmed">24525530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, et al.  Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat Commun. 2015;6:6239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25695629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, et al.  Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol. 2015;17:95–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25438054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, et al.  Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258966</ArticleId>
            <ArticleId IdType="pubmed">22215811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. Cytoskeletal tension inhibits Hippo signaling through an Ajuba–Warts complex. Cell. 2014;158:143–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4082802</ArticleId>
            <ArticleId IdType="pubmed">24995985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Codelia VA, Sun G, Irvine KD. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol. 2014;24:2012–2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4160395</ArticleId>
            <ArticleId IdType="pubmed">25127217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gayer CP, Basson MD. The effects of mechanical forces on intestinal physiology and pathology. Cell Signal. 2009;21:1237–1244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2715958</ArticleId>
            <ArticleId IdType="pubmed">19249356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Regulation of the Hippo–YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3433174</ArticleId>
            <ArticleId IdType="pubmed">22863277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 2013;27:1223–1232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690396</ArticleId>
            <ArticleId IdType="pubmed">23752589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs) Genes Dev. 2012;26:2138–2143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3465735</ArticleId>
            <ArticleId IdType="pubmed">22972936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Hayre M, et al.  The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer. 2013;13:412–424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4068741</ArticleId>
            <ArticleId IdType="pubmed">23640210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu G, et al.  Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene. 2014;34:3536–3546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4721508</ArticleId>
            <ArticleId IdType="pubmed">25195862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng X, et al.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014;25:831–845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4074519</ArticleId>
            <ArticleId IdType="pubmed">24882515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 2014;25:822–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4075337</ArticleId>
            <ArticleId IdType="pubmed">24882516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao Y, et al.  A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J Biochem. 2011;150:199–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21586534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iglesias-Bartolome R, et al.  Inactivation of a Gαs-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol. 2015;17:793–803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449815</ArticleId>
            <ArticleId IdType="pubmed">25961504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012;15:421–431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22482725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasco MY, Loudhaief R, Gallet A. The cellular homeostasis of the gut: what the Drosophila model points out. Histol Histopathol. 2015;30:277–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchon N, Broderick NA, Lemaitre B. Gut homeostasis in a microbial world: insights from Drosophila melanogaster. Nat Rev Microbiol. 2013;11:615–626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23893105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Ajuba family proteins link JNK to Hippo signaling. Sci Signal. 2013;6:ra81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3830546</ArticleId>
            <ArticleId IdType="pubmed">24023255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw RL, et al.  The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development. 2010;137:4147–4158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990206</ArticleId>
            <ArticleId IdType="pubmed">21068063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karpowicz P, Perez J, Perrimon N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development. 2010;137:4135–4145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990205</ArticleId>
            <ArticleId IdType="pubmed">21098564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA. 2010;107:21064–21069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3000252</ArticleId>
            <ArticleId IdType="pubmed">21078993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, et al.  Bantam is essential for Drosophila intestinal stem cell proliferation in response to Hippo signaling. Dev Biol. 2014;385:211–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24262985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol. 2012;22:389–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22305752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, et al.  Suppressor of Deltex mediates Pez degradation and modulates Drosophila midgut homeostasis. Nat Commun. 2015;6:6607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25814387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, et al.  Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science. 2004;304:1164–1166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15155950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang X, et al.  The sterile 20-like kinase tao controls tissue homeostasis by regulating the hippo pathway in Drosophila adult midgut. J Genet Genomics. 2014;41:429–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25160975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration. Cell Res. 2013;23:1133–1146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3760623</ArticleId>
            <ArticleId IdType="pubmed">23896988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, et al.  Brahma is essential for Drosophila intestinal stem cell proliferation and regulated by Hippo signaling. eLife. 2013;2:e00999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3796317</ArticleId>
            <ArticleId IdType="pubmed">24137538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24326621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato T, et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3547360</ArticleId>
            <ArticleId IdType="pubmed">21113151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz J, et al.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. EMBO J. 2012;31:3079–3091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3400017</ArticleId>
            <ArticleId IdType="pubmed">22692129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian H, et al.  A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 2011;478:255–259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4251967</ArticleId>
            <ArticleId IdType="pubmed">21927002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642–656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4197875</ArticleId>
            <ArticleId IdType="pubmed">24825474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camargo FD, et al.  YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054–2060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17980593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157–170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24976009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, et al.  The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010;24:2383–2388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964748</ArticleId>
            <ArticleId IdType="pubmed">21041407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA. 2011;108:E1312–E1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3241824</ArticleId>
            <ArticleId IdType="pubmed">22042863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Ebisuya M, Nishida E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol. 2015;17:7–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25531778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llado V, et al.  Repression of intestinal stem cell function and tumorigenesis through direct phosphorylation of β-catenin and Yap by PKCζ. Cell Rep. 2015;10:740–754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4524805</ArticleId>
            <ArticleId IdType="pubmed">25660024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barry ER, et al.  Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3536889</ArticleId>
            <ArticleId IdType="pubmed">23178811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, et al.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 2015;29:1271–1284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495398</ArticleId>
            <ArticleId IdType="pubmed">26109050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, et al.  Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev. 2015;29:1285–1297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495399</ArticleId>
            <ArticleId IdType="pubmed">26109051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai X, et al.  YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 2015;25:1175–1178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4650621</ArticleId>
            <ArticleId IdType="pubmed">26315483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi K, et al.  A gp130–Src–YAP module links inflammation to epithelial regeneration. Nature. 2015;519:57–U107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4447318</ArticleId>
            <ArticleId IdType="pubmed">25731159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature. 2015;526:715–718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26503053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroncek JD, Reichert WM.  Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. CRC Press; 2008. </Citation>
        </Reference>
        <Reference>
          <Citation>Vanuytsel T, Senger S, Fasano A, Shea-Donohue T. Major signaling pathways in intestinal stem cells. Biochim Biophys Acta. 2013;1830:2410–2426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4408610</ArticleId>
            <ArticleId IdType="pubmed">22922290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003;17:1709–1713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC196179</ArticleId>
            <ArticleId IdType="pubmed">12865297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batlle E, et al.  β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002;111:251–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12408869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korinek V, et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379–383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9697701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X, et al.  The Hippo pathway regulates Wnt/β-catenin signaling. Dev Cell. 2010;18:579–591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20412773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J. 2012;31:1109–1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3297994</ArticleId>
            <ArticleId IdType="pubmed">22234184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  Role of TAZ as mediator of Wnt signaling. Cell. 2012;151:1443–1456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konsavage WM, et al.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem. 2012;287:11730–11739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3320921</ArticleId>
            <ArticleId IdType="pubmed">22337891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338:108–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3706630</ArticleId>
            <ArticleId IdType="pubmed">22956684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HW, et al.  Alternative Wnt signaling activates YAP/TAZ. Cell. 2015;162:780–794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4538707</ArticleId>
            <ArticleId IdType="pubmed">26276632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanDussen KL, et al.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development. 2012;139:488–497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3252352</ArticleId>
            <ArticleId IdType="pubmed">22190634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, Cremona CA, Behrens A. Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease. EMBO Rep. 2015;16:571–581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4428041</ArticleId>
            <ArticleId IdType="pubmed">25855643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Es JH, et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15959515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yimlamai D, et al.  Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324–1338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4136468</ArticleId>
            <ArticleId IdType="pubmed">24906150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang RN, et al.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1:87–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4232216</ArticleId>
            <ArticleId IdType="pubmed">25401122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haramis AP, et al.  De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303:1684–1686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15017003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XC, et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet. 2004;36:1117–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15378062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C, et al.  Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell. 2009;139:757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batts LE, Polk DB, Dubois RN, Kulessa H. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn. 2006;235:1563–1570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16538672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosinski C, et al.  Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology. 2010;139:893–903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2930094</ArticleId>
            <ArticleId IdType="pubmed">20542037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reifenberger J, et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1998;58:1798–1803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9581815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev. 2003;13:34–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12573433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez LA, et al.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009;23:2729–2741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2788333</ArticleId>
            <ArticleId IdType="pubmed">19952108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:2101–2114.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20420949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, et al.  NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol. 2015;25:296–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4426889</ArticleId>
            <ArticleId IdType="pubmed">25601544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhardt AA, et al.  Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008;39:1582–1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720436</ArticleId>
            <ArticleId IdType="pubmed">18703216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam-Himlin DM, et al.  The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer. 2006;37:103–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18175224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, et al.  Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS ONE. 2013;8:e65539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677905</ArticleId>
            <ArticleId IdType="pubmed">23762387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuen HF, et al.  TAZ expression as a prognostic indicator in colorectal cancer. PLoS ONE. 2013;8:e54211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3553150</ArticleId>
            <ArticleId IdType="pubmed">23372686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan J, et al.  Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo. Oncol Rep. 2012;28:179–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22470139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powell SM, et al.  APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1528264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000;103:311–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11057903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–1038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1867011</ArticleId>
            <ArticleId IdType="pubmed">10514384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawford HC, et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 1999;18:2883–2891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10362259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, et al.  Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–1512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9727977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10201372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, Chan TA, Vogelstein B, Kinzler KW. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999;99:335–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3779681</ArticleId>
            <ArticleId IdType="pubmed">10555149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, Maitra A, Anders RA, Taketo MM, Pan D. β-catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015;29:1493–1506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526734</ArticleId>
            <ArticleId IdType="pubmed">26193883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenbluh J, et al.  β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151:1457–1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3530160</ArticleId>
            <ArticleId IdType="pubmed">23245941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, et al.  JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 2009;28:1843–1854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2711188</ArticleId>
            <ArticleId IdType="pubmed">19521338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012;72:379–386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3261582</ArticleId>
            <ArticleId IdType="pubmed">22253282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol. 2011;350:139–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3038240</ArticleId>
            <ArticleId IdType="pubmed">21145886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomlinson V, et al.  JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010;1:e29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3032333</ArticleId>
            <ArticleId IdType="pubmed">21364637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehenni H, et al.  Loss of LKB1 kinase activity in Peutz–Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet. 1998;63:1641–1650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1377635</ArticleId>
            <ArticleId IdType="pubmed">9837816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giardiello FM, et al.  Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med. 1987;316:1511–1514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3587280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz–Jeghers syndrome. Oncogene. 2007;26:7825–7832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17599048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HB, Babcock JT, Wells CD, Quilliam LA. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene. 2013;32:4100–4109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3977597</ArticleId>
            <ArticleId IdType="pubmed">23027127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grivennikov S, et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2667107</ArticleId>
            <ArticleId IdType="pubmed">19185845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bechmann LP, et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–964.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22173168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836–847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15459664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–S53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16447274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21:886–897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17437995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu MZ, et al.  Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer. 2009;115:4576–4585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2811690</ArticleId>
            <ArticleId IdType="pubmed">19551889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KP, et al.  The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA. 2010;107:8248–8253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2889558</ArticleId>
            <ArticleId IdType="pubmed">20404163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16:425–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3023165</ArticleId>
            <ArticleId IdType="pubmed">19878874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song H, et al.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA. 2010;107:1431–1436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824397</ArticleId>
            <ArticleId IdType="pubmed">20080598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu L, et al.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA. 2010;107:1437–1442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824398</ArticleId>
            <ArticleId IdType="pubmed">20080689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, et al.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19:27–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2925178</ArticleId>
            <ArticleId IdType="pubmed">20643348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin F, et al.  Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell. 2013;154:1342–1355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3835333</ArticleId>
            <ArticleId IdType="pubmed">24012335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishio M, et al.  Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest. 2012;122:4505–4518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3533542</ArticleId>
            <ArticleId IdType="pubmed">23143302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Septer S, et al.  Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol. 2012;302:G493–G503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3311431</ArticleId>
            <ArticleId IdType="pubmed">22194415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poncy A, et al.  Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26033091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grijalva JL, et al.  Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307:G196–G204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24875096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte U, et al.  Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009;50:844–851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2914599</ArticleId>
            <ArticleId IdType="pubmed">19575460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herr KJ, et al.  Loss of α-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep. 2014;4:6835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213774</ArticleId>
            <ArticleId IdType="pubmed">25355493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su T, et al.  Two-signal requirement for growth-promoting function of Yap in hepatocytes. eLife. 2015;4:e02948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4363878</ArticleId>
            <ArticleId IdType="pubmed">25667983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mannaerts I, et al.  The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol. 2015;63:679–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25908270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai H, et al.  Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol. 2012;43:1376–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3384990</ArticleId>
            <ArticleId IdType="pubmed">22436626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, et al.  Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102–10115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4496343</ArticleId>
            <ArticleId IdType="pubmed">25826091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, et al.  Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int. 2012;32:38–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4175712</ArticleId>
            <ArticleId IdType="pubmed">22098159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahn EY, Kim JS, Kim GJ, Park YN. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol Cancer Res. 2013;11:748–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23594797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohn BH, et al.  Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma. Clin Cancer Res. 2016;22:1256–1264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5536176</ArticleId>
            <ArticleId IdType="pubmed">26459179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zender L, et al.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006;125:1253–1267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3026384</ArticleId>
            <ArticleId IdType="pubmed">16814713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowalik MA, et al.  Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology. 2011;53:2086–2096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21391223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, et al.  Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 2005;19:1646–1653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15831521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong B, et al.  Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun. 2015;6:5944.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4324535</ArticleId>
            <ArticleId IdType="pubmed">25661872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, et al.  Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012;56:2051–2059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22707013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu P, et al.  HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma. Oncotarget. 2015;6:29048–29059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4745710</ArticleId>
            <ArticleId IdType="pubmed">26315112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, et al.  Bile acid receptors and liver cancer. Curr Pathobiol Rep. 2013;1:29–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3571718</ArticleId>
            <ArticleId IdType="pubmed">23420103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu N, et al.  Hepatocarcinogenesis in FXR−/− mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. Mol Endocrinol. 2012;26:775–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3355555</ArticleId>
            <ArticleId IdType="pubmed">22474109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anakk S, et al.  Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 2013;5:1060–1069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3961013</ArticleId>
            <ArticleId IdType="pubmed">24268772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park YY, et al.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology. 2015;63:159–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4881866</ArticleId>
            <ArticleId IdType="pubmed">26389641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tschaharganeh DF, et al.  Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology. 2013;144:1530–1542.e12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3665638</ArticleId>
            <ArticleId IdType="pubmed">23419361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen S, et al.  A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 2015;25:997–1012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559818</ArticleId>
            <ArticleId IdType="pubmed">26272168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitamant J, et al.  YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep. 2015;10:1692–1707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4565791</ArticleId>
            <ArticleId IdType="pubmed">25772357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu-Chittenden Y, et al.  Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300–1305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3387657</ArticleId>
            <ArticleId IdType="pubmed">22677547</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27147489</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1759-5053</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2016</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nature reviews. Gastroenterology &amp; hepatology</Title>
          <ISOAbbreviation>Nat Rev Gastroenterol Hepatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Hippo pathway in intestinal regeneration and disease.</ArticleTitle>
        <Pagination>
          <StartPage>324</StartPage>
          <EndPage>337</EndPage>
          <MedlinePgn>324-37</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrgastro.2016.59</ELocationID>
        <Abstract>
          <AbstractText>The Hippo pathway is a signalling cascade conserved from Drosophila melanogaster to mammals. The mammalian core kinase components comprise MST1 and MST2, SAV1, LATS1 and LATS2 and MOB1A and MOB1B. The transcriptional co-activators YAP1 and TAZ are the downstream effectors of the Hippo pathway and regulate target gene expression. Hippo signalling has crucial roles in the control of organ size, tissue homeostasis and regeneration, and dysregulation of the Hippo pathway can lead to uncontrolled cell growth and malignant transformation. Mammalian intestine consists of a stem cell compartment as well as differentiated cells, and its ability to regenerate rapidly after injury makes it an excellent model system to study tissue homeostasis, regeneration and tumorigenesis. Several studies have established the important role of the Hippo pathway in these processes. In addition, crosstalk between Hippo and other signalling pathways provides tight, yet versatile, regulation of tissue homeostasis. In this Review, we summarize studies on the role of the Hippo pathway in the intestine on these physiological processes and the underlying mechanisms responsible, and discuss future research directions and potential therapeutic strategies targeting Hippo signalling in intestinal disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Audrey W</ForeName>
            <Initials>AW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meng</LastName>
            <ForeName>Zhipeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Kun-Liang</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 CA023100</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA132809</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R35 CA196878</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 GM007752</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Nat Rev Gastroenterol Hepatol</MedlineTA>
        <NlmUniqueID>101500079</NlmUniqueID>
        <ISSNLinking>1759-5045</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000091102">YAP-Signaling Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C088374">YAP1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.-</RegistryNumber>
          <NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.1.-</RegistryNumber>
          <NameOfSubstance UI="C108675">TAFAZZIN protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000217" MajorTopicYN="N">Acyltransferases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007420" MajorTopicYN="N">Intestine, Large</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012038" MajorTopicYN="N">Regeneration</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091102" MajorTopicYN="N">YAP-Signaling Proteins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Competing interests statement</b>. The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27147489</ArticleId>
        <ArticleId IdType="mid">NIHMS874810</ArticleId>
        <ArticleId IdType="pmc">PMC5642988</ArticleId>
        <ArticleId IdType="doi">10.1038/nrgastro.2016.59</ArticleId>
        <ArticleId IdType="pii">nrgastro.2016.59</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barry ER, Camargo FD. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol. 2013;25:247–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23312716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94:1287–1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25287865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246–257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23467301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4562315</ArticleId>
            <ArticleId IdType="pubmed">25592648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Meng Z, Plouffe SW, Guan KL. Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol. 2015;77:201–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bossuyt W, et al.  An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene. 2014;33:1218–1228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4613760</ArticleId>
            <ArticleId IdType="pubmed">23563179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4701972</ArticleId>
            <ArticleId IdType="pubmed">26728553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9:534–546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7698644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7743921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003;114:445–456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003;5:914–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol. 2003;5:921–927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14502295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia J, Zhang W, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 2003;17:2514–2519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC218145</ArticleId>
            <ArticleId IdType="pubmed">14561774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003;114:457–467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12941274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kango-Singh M, et al.  Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development. 2002;129:5719–5730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12421711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapon N, et al.  salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002;110:467–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12202036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai ZC, et al.  Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell. 2005;120:675–685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15766530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122:421–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16096061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell. 2006;126:767–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16923395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei X, Shimizu T, Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 2007;26:1772–1781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1847660</ArticleId>
            <ArticleId IdType="pubmed">17347649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Liu Y, Zheng Y, Dong J, Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell. 2008;14:388–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18258486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, et al.  Identification of Happyhour/MAP4K as alternative Hpo/Mst-like kinases in the Hippo kinase cascade. Dev Cell. 2015;34:642–655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4589524</ArticleId>
            <ArticleId IdType="pubmed">26364751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, et al.  The conserved misshapen–warts–Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell. 2014;31:291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4254555</ArticleId>
            <ArticleId IdType="pubmed">25453828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, et al.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4600732</ArticleId>
            <ArticleId IdType="pubmed">26437443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staley BK, Irvine KD. Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol. 2010;20:1580–1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2955330</ArticleId>
            <ArticleId IdType="pubmed">20727758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27:355–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3589553</ArticleId>
            <ArticleId IdType="pubmed">23431053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei QY, et al.  TAZ promotes cell proliferation and epithelial–mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol. 2008;28:2426–2436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268418</ArticleId>
            <ArticleId IdType="pubmed">18227151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141:1614–1626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24715453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glantschnig H, Rodan GA, Reszka AA. Mapping of MST1 kinase sites of phosphorylation. Activation and autophosphorylation. J Biol Chem. 2002;277:42987–42996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12223493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KK, Yonehara S. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST) J Biol Chem. 2002;277:12351–12358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11805089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creasy CL, Ambrose DM, Chernoff J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J Biol Chem. 1996;271:21049–21053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8702870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang E, et al.  Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA. 2007;104:9236–9241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1890478</ArticleId>
            <ArticleId IdType="pubmed">17517604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni L, Zheng Y, Hara M, Pan D, Luo X. Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling. Genes Dev. 2015;29:1416–1431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4511216</ArticleId>
            <ArticleId IdType="pubmed">26108669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Callus BA, Verhagen AM, Vaux DL. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006;273:4264–4276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16930133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan EH, et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076–2086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15688006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747–2761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2045129</ArticleId>
            <ArticleId IdType="pubmed">17974916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 2010;24:72–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2802193</ArticleId>
            <ArticleId IdType="pubmed">20048001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22:1962–1971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2492741</ArticleId>
            <ArticleId IdType="pubmed">18579750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J, et al.  Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–1133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666353</ArticleId>
            <ArticleId IdType="pubmed">17889654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami H, et al.  LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71:873–883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21245096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med. 2015;21:212–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4385444</ArticleId>
            <ArticleId IdType="pubmed">25702974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13:63–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4167640</ArticleId>
            <ArticleId IdType="pubmed">24336504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulzke JD, et al.  Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 2009;1165:294–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19538319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paramasivam M, Sarkeshik A, Yates JR, 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725–3733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3183025</ArticleId>
            <ArticleId IdType="pubmed">21832154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3012936</ArticleId>
            <ArticleId IdType="pubmed">21205866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu J, et al.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell. 2010;18:288–299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2858562</ArticleId>
            <ArticleId IdType="pubmed">20159598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell. 2010;18:300–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2845807</ArticleId>
            <ArticleId IdType="pubmed">20159599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell. 2010;18:309–316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20159600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohseni M, et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway. Nat Cell Biol. 2014;16:108–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4159053</ArticleId>
            <ArticleId IdType="pubmed">24362629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, et al.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500–510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380774</ArticleId>
            <ArticleId IdType="pubmed">25751140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, et al.  AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17:490–499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380807</ArticleId>
            <ArticleId IdType="pubmed">25751139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeRan M, et al.  Energy stress regulates hippo–YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9:495–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4223634</ArticleId>
            <ArticleId IdType="pubmed">25373897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol. 2006;16:2101–2110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17045801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho E, et al.  Delineation of a Fat tumor suppressor pathway. Nat Genet. 2006;38:1142–1150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16980976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol. 2006;16:2081–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willecke M, et al.  The Fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol. 2006;16:2090–2100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16996265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA. 2011;108:11930–11935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3141988</ArticleId>
            <ArticleId IdType="pubmed">21730131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori M, et al.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156:893–906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3982296</ArticleId>
            <ArticleId IdType="pubmed">24581491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. J Biol Chem. 2014;289:1886–1891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3900939</ArticleId>
            <ArticleId IdType="pubmed">24324261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao D, et al.  A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3962829</ArticleId>
            <ArticleId IdType="pubmed">24525530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, et al.  Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat Commun. 2015;6:6239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25695629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, et al.  Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol. 2015;17:95–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25438054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, et al.  Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21654799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, et al.  Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012;26:54–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258966</ArticleId>
            <ArticleId IdType="pubmed">22215811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rauskolb C, Sun S, Sun G, Pan Y, Irvine KD. Cytoskeletal tension inhibits Hippo signaling through an Ajuba–Warts complex. Cell. 2014;158:143–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4082802</ArticleId>
            <ArticleId IdType="pubmed">24995985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Codelia VA, Sun G, Irvine KD. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol. 2014;24:2012–2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4160395</ArticleId>
            <ArticleId IdType="pubmed">25127217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gayer CP, Basson MD. The effects of mechanical forces on intestinal physiology and pathology. Cell Signal. 2009;21:1237–1244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2715958</ArticleId>
            <ArticleId IdType="pubmed">19249356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Regulation of the Hippo–YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3433174</ArticleId>
            <ArticleId IdType="pubmed">22863277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 2013;27:1223–1232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690396</ArticleId>
            <ArticleId IdType="pubmed">23752589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs) Genes Dev. 2012;26:2138–2143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3465735</ArticleId>
            <ArticleId IdType="pubmed">22972936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Hayre M, et al.  The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer. 2013;13:412–424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4068741</ArticleId>
            <ArticleId IdType="pubmed">23640210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu G, et al.  Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene. 2014;34:3536–3546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4721508</ArticleId>
            <ArticleId IdType="pubmed">25195862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng X, et al.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014;25:831–845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4074519</ArticleId>
            <ArticleId IdType="pubmed">24882515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu FX, et al.  Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 2014;25:822–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4075337</ArticleId>
            <ArticleId IdType="pubmed">24882516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao Y, et al.  A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J Biochem. 2011;150:199–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21586534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iglesias-Bartolome R, et al.  Inactivation of a Gαs-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol. 2015;17:793–803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449815</ArticleId>
            <ArticleId IdType="pubmed">25961504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012;15:421–431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22482725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasco MY, Loudhaief R, Gallet A. The cellular homeostasis of the gut: what the Drosophila model points out. Histol Histopathol. 2015;30:277–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchon N, Broderick NA, Lemaitre B. Gut homeostasis in a microbial world: insights from Drosophila melanogaster. Nat Rev Microbiol. 2013;11:615–626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23893105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Ajuba family proteins link JNK to Hippo signaling. Sci Signal. 2013;6:ra81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3830546</ArticleId>
            <ArticleId IdType="pubmed">24023255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw RL, et al.  The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development. 2010;137:4147–4158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990206</ArticleId>
            <ArticleId IdType="pubmed">21068063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karpowicz P, Perez J, Perrimon N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development. 2010;137:4135–4145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2990205</ArticleId>
            <ArticleId IdType="pubmed">21098564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA. 2010;107:21064–21069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3000252</ArticleId>
            <ArticleId IdType="pubmed">21078993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, et al.  Bantam is essential for Drosophila intestinal stem cell proliferation in response to Hippo signaling. Dev Biol. 2014;385:211–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24262985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H. Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol. 2012;22:389–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22305752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, et al.  Suppressor of Deltex mediates Pez degradation and modulates Drosophila midgut homeostasis. Nat Commun. 2015;6:6607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25814387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, et al.  Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science. 2004;304:1164–1166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15155950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang X, et al.  The sterile 20-like kinase tao controls tissue homeostasis by regulating the hippo pathway in Drosophila adult midgut. J Genet Genomics. 2014;41:429–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25160975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren F, et al.  Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration. Cell Res. 2013;23:1133–1146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3760623</ArticleId>
            <ArticleId IdType="pubmed">23896988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, et al.  Brahma is essential for Drosophila intestinal stem cell proliferation and regulated by Hippo signaling. eLife. 2013;2:e00999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3796317</ArticleId>
            <ArticleId IdType="pubmed">24137538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24326621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato T, et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3547360</ArticleId>
            <ArticleId IdType="pubmed">21113151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18808327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker N, et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz J, et al.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. EMBO J. 2012;31:3079–3091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3400017</ArticleId>
            <ArticleId IdType="pubmed">22692129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian H, et al.  A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 2011;478:255–259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4251967</ArticleId>
            <ArticleId IdType="pubmed">21927002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642–656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4197875</ArticleId>
            <ArticleId IdType="pubmed">24825474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camargo FD, et al.  YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054–2060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17980593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157–170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24976009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, et al.  The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010;24:2383–2388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964748</ArticleId>
            <ArticleId IdType="pubmed">21041407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA. 2011;108:E1312–E1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3241824</ArticleId>
            <ArticleId IdType="pubmed">22042863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Ebisuya M, Nishida E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol. 2015;17:7–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25531778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llado V, et al.  Repression of intestinal stem cell function and tumorigenesis through direct phosphorylation of β-catenin and Yap by PKCζ. Cell Rep. 2015;10:740–754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4524805</ArticleId>
            <ArticleId IdType="pubmed">25660024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barry ER, et al.  Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3536889</ArticleId>
            <ArticleId IdType="pubmed">23178811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moroishi T, et al.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 2015;29:1271–1284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495398</ArticleId>
            <ArticleId IdType="pubmed">26109050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, et al.  Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev. 2015;29:1285–1297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4495399</ArticleId>
            <ArticleId IdType="pubmed">26109051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai X, et al.  YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 2015;25:1175–1178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4650621</ArticleId>
            <ArticleId IdType="pubmed">26315483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi K, et al.  A gp130–Src–YAP module links inflammation to epithelial regeneration. Nature. 2015;519:57–U107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4447318</ArticleId>
            <ArticleId IdType="pubmed">25731159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature. 2015;526:715–718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26503053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroncek JD, Reichert WM.  Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. CRC Press; 2008. </Citation>
        </Reference>
        <Reference>
          <Citation>Vanuytsel T, Senger S, Fasano A, Shea-Donohue T. Major signaling pathways in intestinal stem cells. Biochim Biophys Acta. 2013;1830:2410–2426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4408610</ArticleId>
            <ArticleId IdType="pubmed">22922290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003;17:1709–1713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC196179</ArticleId>
            <ArticleId IdType="pubmed">12865297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batlle E, et al.  β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002;111:251–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12408869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korinek V, et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379–383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9697701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varelas X, et al.  The Hippo pathway regulates Wnt/β-catenin signaling. Dev Cell. 2010;18:579–591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20412773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J. 2012;31:1109–1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3297994</ArticleId>
            <ArticleId IdType="pubmed">22234184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzolin L, et al.  Role of TAZ as mediator of Wnt signaling. Cell. 2012;151:1443–1456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konsavage WM, et al.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem. 2012;287:11730–11739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3320921</ArticleId>
            <ArticleId IdType="pubmed">22337891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338:108–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3706630</ArticleId>
            <ArticleId IdType="pubmed">22956684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HW, et al.  Alternative Wnt signaling activates YAP/TAZ. Cell. 2015;162:780–794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4538707</ArticleId>
            <ArticleId IdType="pubmed">26276632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2827930</ArticleId>
            <ArticleId IdType="pubmed">19379690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanDussen KL, et al.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development. 2012;139:488–497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3252352</ArticleId>
            <ArticleId IdType="pubmed">22190634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, Cremona CA, Behrens A. Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease. EMBO Rep. 2015;16:571–581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4428041</ArticleId>
            <ArticleId IdType="pubmed">25855643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Es JH, et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15959515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yimlamai D, et al.  Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324–1338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4136468</ArticleId>
            <ArticleId IdType="pubmed">24906150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang RN, et al.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1:87–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4232216</ArticleId>
            <ArticleId IdType="pubmed">25401122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haramis AP, et al.  De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303:1684–1686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15017003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XC, et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet. 2004;36:1117–1121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15378062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C, et al.  Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell. 2009;139:757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batts LE, Polk DB, Dubois RN, Kulessa H. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn. 2006;235:1563–1570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16538672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosinski C, et al.  Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology. 2010;139:893–903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2930094</ArticleId>
            <ArticleId IdType="pubmed">20542037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reifenberger J, et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1998;58:1798–1803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9581815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev. 2003;13:34–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12573433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez LA, et al.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009;23:2729–2741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2788333</ArticleId>
            <ArticleId IdType="pubmed">19952108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:2101–2114.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20420949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, et al.  NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol. 2015;25:296–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4426889</ArticleId>
            <ArticleId IdType="pubmed">25601544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhardt AA, et al.  Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008;39:1582–1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720436</ArticleId>
            <ArticleId IdType="pubmed">18703216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam-Himlin DM, et al.  The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer. 2006;37:103–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18175224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, et al.  Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS ONE. 2013;8:e65539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677905</ArticleId>
            <ArticleId IdType="pubmed">23762387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuen HF, et al.  TAZ expression as a prognostic indicator in colorectal cancer. PLoS ONE. 2013;8:e54211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3553150</ArticleId>
            <ArticleId IdType="pubmed">23372686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan J, et al.  Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo. Oncol Rep. 2012;28:179–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22470139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powell SM, et al.  APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1528264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000;103:311–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11057903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–1038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1867011</ArticleId>
            <ArticleId IdType="pubmed">10514384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawford HC, et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 1999;18:2883–2891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10362259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, et al.  Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–1512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9727977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10201372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He TC, Chan TA, Vogelstein B, Kinzler KW. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999;99:335–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3779681</ArticleId>
            <ArticleId IdType="pubmed">10555149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai J, Maitra A, Anders RA, Taketo MM, Pan D. β-catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015;29:1493–1506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526734</ArticleId>
            <ArticleId IdType="pubmed">26193883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenbluh J, et al.  β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151:1457–1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3530160</ArticleId>
            <ArticleId IdType="pubmed">23245941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancho R, et al.  JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 2009;28:1843–1854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2711188</ArticleId>
            <ArticleId IdType="pubmed">19521338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012;72:379–386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3261582</ArticleId>
            <ArticleId IdType="pubmed">22253282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun G, Irvine KD. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol. 2011;350:139–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3038240</ArticleId>
            <ArticleId IdType="pubmed">21145886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomlinson V, et al.  JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010;1:e29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3032333</ArticleId>
            <ArticleId IdType="pubmed">21364637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehenni H, et al.  Loss of LKB1 kinase activity in Peutz–Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet. 1998;63:1641–1650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1377635</ArticleId>
            <ArticleId IdType="pubmed">9837816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giardiello FM, et al.  Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med. 1987;316:1511–1514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3587280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz–Jeghers syndrome. Oncogene. 2007;26:7825–7832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17599048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HB, Babcock JT, Wells CD, Quilliam LA. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene. 2013;32:4100–4109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3977597</ArticleId>
            <ArticleId IdType="pubmed">23027127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grivennikov S, et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2667107</ArticleId>
            <ArticleId IdType="pubmed">19185845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bechmann LP, et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–964.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22173168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836–847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15459664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–S53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16447274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21:886–897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17437995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu MZ, et al.  Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer. 2009;115:4576–4585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2811690</ArticleId>
            <ArticleId IdType="pubmed">19551889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KP, et al.  The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA. 2010;107:8248–8253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2889558</ArticleId>
            <ArticleId IdType="pubmed">20404163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou D, et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16:425–438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3023165</ArticleId>
            <ArticleId IdType="pubmed">19878874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song H, et al.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA. 2010;107:1431–1436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824397</ArticleId>
            <ArticleId IdType="pubmed">20080598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu L, et al.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA. 2010;107:1437–1442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2824398</ArticleId>
            <ArticleId IdType="pubmed">20080689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, et al.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19:27–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2925178</ArticleId>
            <ArticleId IdType="pubmed">20643348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin F, et al.  Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell. 2013;154:1342–1355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3835333</ArticleId>
            <ArticleId IdType="pubmed">24012335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishio M, et al.  Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest. 2012;122:4505–4518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3533542</ArticleId>
            <ArticleId IdType="pubmed">23143302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Septer S, et al.  Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol. 2012;302:G493–G503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3311431</ArticleId>
            <ArticleId IdType="pubmed">22194415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poncy A, et al.  Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26033091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grijalva JL, et al.  Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307:G196–G204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24875096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte U, et al.  Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009;50:844–851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2914599</ArticleId>
            <ArticleId IdType="pubmed">19575460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herr KJ, et al.  Loss of α-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep. 2014;4:6835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213774</ArticleId>
            <ArticleId IdType="pubmed">25355493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su T, et al.  Two-signal requirement for growth-promoting function of Yap in hepatocytes. eLife. 2015;4:e02948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4363878</ArticleId>
            <ArticleId IdType="pubmed">25667983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mannaerts I, et al.  The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol. 2015;63:679–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25908270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai H, et al.  Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol. 2012;43:1376–1385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3384990</ArticleId>
            <ArticleId IdType="pubmed">22436626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, et al.  Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102–10115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4496343</ArticleId>
            <ArticleId IdType="pubmed">25826091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, et al.  Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int. 2012;32:38–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4175712</ArticleId>
            <ArticleId IdType="pubmed">22098159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahn EY, Kim JS, Kim GJ, Park YN. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol Cancer Res. 2013;11:748–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23594797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohn BH, et al.  Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma. Clin Cancer Res. 2016;22:1256–1264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5536176</ArticleId>
            <ArticleId IdType="pubmed">26459179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zender L, et al.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006;125:1253–1267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3026384</ArticleId>
            <ArticleId IdType="pubmed">16814713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowalik MA, et al.  Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology. 2011;53:2086–2096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21391223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, et al.  Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 2005;19:1646–1653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15831521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong B, et al.  Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun. 2015;6:5944.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4324535</ArticleId>
            <ArticleId IdType="pubmed">25661872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, et al.  Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012;56:2051–2059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22707013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu P, et al.  HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma. Oncotarget. 2015;6:29048–29059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4745710</ArticleId>
            <ArticleId IdType="pubmed">26315112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, et al.  Bile acid receptors and liver cancer. Curr Pathobiol Rep. 2013;1:29–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3571718</ArticleId>
            <ArticleId IdType="pubmed">23420103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu N, et al.  Hepatocarcinogenesis in FXR−/− mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. Mol Endocrinol. 2012;26:775–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3355555</ArticleId>
            <ArticleId IdType="pubmed">22474109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anakk S, et al.  Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 2013;5:1060–1069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3961013</ArticleId>
            <ArticleId IdType="pubmed">24268772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park YY, et al.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology. 2015;63:159–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4881866</ArticleId>
            <ArticleId IdType="pubmed">26389641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tschaharganeh DF, et al.  Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology. 2013;144:1530–1542.e12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3665638</ArticleId>
            <ArticleId IdType="pubmed">23419361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen S, et al.  A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 2015;25:997–1012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559818</ArticleId>
            <ArticleId IdType="pubmed">26272168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitamant J, et al.  YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep. 2015;10:1692–1707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4565791</ArticleId>
            <ArticleId IdType="pubmed">25772357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu-Chittenden Y, et al.  Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300–1305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3387657</ArticleId>
            <ArticleId IdType="pubmed">22677547</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
